Goldman Sachs’ investment arm agrees €2bn deal for drugmaker Synthon

December 16, 2024

Unlock the Editor’s Digest without costRoula Khalaf, Editor of the FT, selects her favorite tales on this weekly publication.Goldman Sachs Asset Administration has agreed a greater than €2bn deal to ...

Wall Street slashes stock market forecasts amid Trump tariff fears

Canary Capital files for staked TRX ETF

Figma tells AI startup to stop using the term ‘Dev Mode’

Here’s How Much You Would Have Made Owning argenx Stock In The Last 5 Years – argenx (NASDAQ:ARGX)

ECHOTRADE TELEGRAM TO MT5 COPIER – SETUP AND INSTALLATION GUIDE – My Trading – 18 April 2025

Takeover speculation likely to continue for TT Electronics

Trump: We have a really good chance of getting a Russia-Ukraine deal

UK says transfer of deep-sea mining permits could prompt security review

How I’m staying calm when markets are uncertain

Fed's Daly: Cautiously optimistic on inflation path, maintains call for gradual cuts

Why stablecoins will delay Bitcoin’s breakout to $90K

Should investors dump U.S. stocks for international equities? Experts weigh in

Tag: Synthon

Goldman Sachs’ investment arm agrees €2bn deal for drugmaker Synthon

Equinor scales back renewables push 7 years after ditching ‘oil’ from its name

Suleiman Levels limited V 3.00 Update and Offer – Analytics & Forecasts – 5 January 2025

How to get from the me to the we society

Niels Troost has a staggering story to tell about how he got sanctioned

Why America’s economy is soaring ahead of its rivals

Dollar climbs after Donald Trump’s Brics tariff threat and French political woes

Nato chief Mark Rutte’s warning to Trump

Top Federal Reserve official warns progress on taming US inflation ‘may be stalling’

Wall Street slashes stock market forecasts amid Trump tariff fears

Canary Capital files for staked TRX ETF

Figma tells AI startup to stop using the term ‘Dev Mode’

Here’s How Much You Would Have Made Owning argenx Stock In The Last 5 Years – argenx (NASDAQ:ARGX)

Live Prices